Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD FormulationsSara Malaca, Massimo Gottardi, Federica Pigliasco, et al.
Complementary Therapies in Medicine|June 9, 2020
Safety and pharmacokinetics of medical cannabis preparation in a monocentric series of young patients with drug resistant epilepsyMarcella Gherzi, Giulia Milano, Carmen Fucile, et al.
Epilepsia Open|September 19, 2024
A VAMS-based LC-MS/MS method for precise cenobamate quantification in epilepsy (patients)Federica Pigliasco, Alessia Cafaro, Sebastiano Barco, et al.
Therapeutic Drug Monitoring|May 28, 2026
"Standard" Is More Than Enough: Therapeutic Drug Monitoring Confirms Early Target Attainment of Teicoplanin Regimens in Pediatric PatientsMarcello Mariani, Alessia Cafaro, Silvia M Orsi, et al.
Clinical Biochemistry|March 2, 2019
Plasma free metanephrines for diagnosis of neuroblastoma patientsSebastiano Barco, Iedan Verly, Maria Valeria Corrias, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Analysis of Cannabinoids Concentration in Cannabis Oil Galenic Preparations: Harmonization between Three Laboratories in Northern ItalyAlice Palermiti, Alessia Cafaro, Sebastiano Barco, et al.
JCO Precision Oncology|January 27, 2022
Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With NeuroblastomaIedan R N Verly, Yvette A H Matser, René Leen, et al.
Oncotarget|September 9, 2017
Altered erythropoiesis and decreased number of erythrocytes in children with neuroblastomaFabio Morandi, Sebastiano Barco, Sara Stigliani, et al.
Pageof 7